Clinical Trial Update: A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the compound 608 in non-radiographic axial spondyloarthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis
• Non-radiographic Axial Spondyloarthritis

Drugs mentioned

• 608

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Axial Spondyloarthritis | Phase 2 | Status: RECRUITING